BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6420136)

  • 1. Adverse dermatologic reaction to transdermal nitroglycerin.
    Letendre PW; Barr C; Wilkens K
    Drug Intell Clin Pharm; 1984 Jan; 18(1):69-70. PubMed ID: 6420136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients.
    Vaillant L; Biette S; Machet L; Constans T; Monpère C
    Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe allergic contact dermatitis secondary to nitroglycerin in a transdermal therapeutic system.
    Topaz O; Abraham D
    Ann Allergy; 1987 Nov; 59(5):365-6. PubMed ID: 3120627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Glode JE; Hilty RW; Hughes SO; Koeppl CG; Kovaric TR; Wyskoarko NP
    Clin Ther; 1989; 11(1):23-31. PubMed ID: 2497985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis secondary to transdermal nitroglycerin.
    Rosenfeld AS; White WB
    Am Heart J; 1984 Oct; 108(4 Pt 1):1061-2. PubMed ID: 6237565
    [No Abstract]   [Full Text] [Related]  

  • 7. Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch.
    Wick KA; Wick SM; Hawkinson RW; Holtzman JL
    Clin Ther; 1989; 11(3):417-24. PubMed ID: 2501033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA; Breaux PC; Ibrahim F
    Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational allergic contact dermatitis caused by nitroglycerin.
    Kanerva L; Laine R; Jolanki R; Tarvainen K; Estlander T; Helander I
    Contact Dermatitis; 1991 May; 24(5):356-62. PubMed ID: 1832616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and Deponit.
    Chinoy DA; Camp J; Elchahal S; Godoy C; Grossman W; Hai H; Hamilton W; Kushner M; McGreevy M; Mulvihill RJ
    Clin Ther; 1989; 11(5):678-84. PubMed ID: 2509071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nitroglycerin systems: methods for comparison.
    Harrison LI; Riedel DJ
    Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population.
    Kochak GM; Berner B; Leal M; Sambol NC
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):443-59. PubMed ID: 1287196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two transdermal nitroglycerin systems: Transderm-Nitro and Nitro-Dur.
    Riley S; Morris B; Walker L; Reese P; White L
    Clin Ther; 1992; 14(3):438-45. PubMed ID: 1638585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of transcutaneous nitroglycerin patches by patients with angina pectoris.
    Schrader BJ; Bauman JL; Zeller FP; Shanes JG; Rich S
    Pharmacotherapy; 1986; 6(2):83-6. PubMed ID: 3086849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two transdermal nitroglycerin systems.
    Godoy C; Greenspahn BR; Kushner MJ; Lahti RE; Levy RA; Reese P; Reynolds GM; Rice SC
    Clin Ther; 1986; 8(6):689-93. PubMed ID: 3098427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from transdermal nitroglycerin.
    Carmichael AJ; Foulds IS
    Contact Dermatitis; 1989 Aug; 21(2):113-4. PubMed ID: 2530050
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Brown SG; Dougherty PJ; Fogel MA; Hash VW; Rietbrock MJ
    Clin Ther; 1989; 11(1):15-22. PubMed ID: 2497982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative acceptance of three transdermal nitroglycerin placebo patches.
    Rayment CM; Kaul AF; Garfield JM
    Am J Hosp Pharm; 1985 Jun; 42(6):1362-5. PubMed ID: 3925770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.